Skip to Content

Institute of Biomedical Research Corp - Stock Quote MRES

Rating as of

Morningstar's Institute of Biomedical Research Corp Stock Analysis

Valuation
Currency in USD
Is it the right time to buy or sell?
Is it the right time to buy or sell?

1-Star Price

INVESTOR

5-Star Price

INVESTOR

Economic Moat

INVESTOR

About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

Key Statistics - MRES

Institute of Biomedical Research Corp's Company Profile

Business Description

Institute of Biomedical Research Corp is a biomedical research and development company. Its services include research and development, quality control, standardization of pharmaceuticals, cosmetics, and food products. The Company also provides long-term biomedical and environmental research projects, develops new diagnostic biomedical technologies and innovative experimental medical treatments. The Institute has expanded its research to also include the augmentation of traditional medicine and the emerging science of medicinal mushrooms.

Contact
Jele Andrijasevic 2
Niksic, 81400, Montenegro
T +382 20663075
Industry Biotechnology
Most Recent Earnings Dec 31, 2010
Fiscal Year End Mar 31, 2022
Stock Type Cyclical
Employees